3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow GC1113: new trials by email Literature Review of GC1113 trials Research Report on GC1113
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects GX-E2 - Healthy | Phase 1 | Completed | Genexine, Inc. | 10 | 2014-11-01 | 2015-01-29 |
| Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD) GX-E2, NESP, MIRCERA - Anemia, Chronic Kidney Disease | Phase 2 | Completed | Genexine, Inc. | 257 | 2014-04-15 | 2017-10-16 |
| To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin GC1113, Darbepoetin alfa - Healthy Volunteer | Phase 1 | Completed | Green Cross Corporation | 100 | 2011-06-01 | 2012-07-19 |
Anemia (1) · Renal Insufficiency, Chronic (1)
Genexine, Inc. (2) · Green Cross Corporation (1)
South Korea (2)
Byung Chul Shin, MD (1) · Chul-Woo Yang, MD (1) · Eun Young Seong, MD (1) · Hyung Wook Kim, MD (1) · Ki Young Na, MD (1) · Kyung-Sang Yu, MD., Ph.D (1) · KyungSang Yu, M.D. (1) · Sangho Lee, MD (1) · Seok Joon Shin, MD (1) · Su-Hyun Kim, MD (1) · Sug Kyun Shin, MD (1) · Won Kim, MD (1) · Yong-Lim Kim, MD (1)